Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study aims to evaluate the efficacy of ultrasound-guided Sacral Erector Spinae Plane (ESP) block for postoperative analgesia management in patients undergoing pilonidal sinus surgery under general anesthesia
Severe pain after pilonidal sinus surgery is a significant problem that reduces patient comfort. In this randomized, prospective study, patients will be divided into two groups (Sacral ESPB group and control group) using a computer randomization method before the surgery. In the Sacral ESPB group, the block will be performed under ultrasound guidance using a 20 ml local anesthetic volume immediately after the surgical procedure and before extubation. The study will compare postoperative rescue analgesic requirement, opioid consumption, pain scores (NRS), and the incidence of side effects and complications
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Sacral ESPB Group | Experimental |
| |
| Control Group | Active Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Sacral Erector Spinae Plane Block | Procedure | Immediately after the surgical procedure and before extubation, ultrasound-guided (Vivid Q) Sacral ESPB will be applied to the patient in the prone position using a total volume of 20 ml. |
| Measure | Description | Time Frame |
|---|---|---|
| Total postoperative rescue analgesic (opioid) consumption. | Total amount of intravenous tramadol administered as a rescue analgesic will be recorded | At 24 hours postoperatively (Cumulative total over the 24-hour period) |
| Measure | Description | Time Frame |
|---|---|---|
| Postoperative pain scores evaluated by the Numeric Rating Scale (NRS) | Pain scores will be evaluated at rest and during movement using a 0-10 NRS (0= no pain, 10= most severe pain). | At 1, 3, 6, 12, 18, and 24 hours postoperatively. |
| Incidence of opioid-related side effects and block-related complications. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Istanbul Medipol University | Istanbul | Turkey (Türkiye) |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D010864 | Pilonidal Sinus |
| ID | Term |
|---|---|
| D003560 | Cysts |
| D009369 | Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
Single Blind (Outcomes Assessor). Postoperative patient evaluation will be performed by another anesthesiologist who was not involved in the procedure.
| Standard Postoperative Analgesia | Drug | No block will be applied to this group. Both groups will receive intravenous 400 mg ibuprofen and 100 mg tramadol 20 minutes before the end of the surgery, and routine 1000 mg paracetamol every 8 hours postoperatively |
|
Occurrence of side effects such as nausea, vomiting, itching, allergic reactions, and complications like hematoma will be recorded. |
| During the 24-hour postoperative period. |